Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Advanced Cancer|Breast Cancer|Gastric Cancer|Esophageal Cancer|Colorectal Cancer
Interventions: DRUG: Pembrolizumab|DRUG: Trastuzumab|DRUG: ado-trastuzumab emtansine|DRUG: Cetuximab
Sponsor: Western Regional Medical Center